Active Ingredient History
Bezlotoxumab, sold under the brand name Zinplava, is a human monoclonal antibody designed for the prevention of recurrence of Clostridioides difficile infections. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Clostridium Infections (approved 2016)
Clostridioides difficile (Phase 4)
Clostridium Infections (Phase 4)
Colitis, Ulcerative (Phase 4)
Crohn Disease (Phase 4)
Enterocolitis, Pseudomembranous (Phase 4)
Gastrointestinal Microbiome (Phase 2)
Infections (Phase 2)
Inflammatory Bowel Diseases (Phase 4)
Mortality (Phase 2)
Organ Dysfunction Scores (Phase 2)
Sepsis (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue